RSS

Oxford BioDynamics

Oxford BioDynamics is expanding its biomarker discovery programme for the development of companion diagnostic tests for Amyotrophic Lateral Sclerosis (ALS), using its EpiSwitch technology Read more

News

Dr Alexandre Akoulitchev, Oxford BioDynamics, talks to EPM about biomarkers aiding diagnostics and new treatments Read more

Opinion